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Introduction
Arcanobacterium pyogenes is a Gram-positive bacterial pathogen of livestock. An important virulence factor of A. pyogenes is the cytolytic toxin pyolysin (PLO). This toxin is a member of the large group of toxins known as the Cholesterol Dependent Cytolysins (CDC), which take their name from their absolute dependence on cholesterol in the target membrane for activity.
These toxins form exceptionally large oligomeric trans-membrane pores (1) , which consist of 40-50 monomers and have diameters of up to 30 nm (2) .
Crystallographic studies on other members of the CDC family, namely perfringolysin O (PFO) and intermedilysin (ILY) show that the monomeric toxin molecule is elongated and contains four domains rich in β-sheet structure (3; 4) . Upon binding to a target membrane, molecules diffuse laterally on the surface, interact with other bound CDC monomers, and form a pre-pore complex (5) . Subsequently, a profound conformational change occurs that results in the formation of the trans-membrane pore (6) . During this change, domain 2 dissociates from domain 3, whereupon two initially α-helical segments in domain three change shape into β-hairpins and become deeply inserted into the membrane (7) .
In a previous study on the homologous toxin perfringolysin O, it had been reported that introduction of a disulfide bond between domains 2 and 3 prevented membrane insertion, while still allowing the assembly of pre-pore oligomers (8) . This observation suggests that conformational flexibility of domain 2 relative to domain 3 is not required up to the pre-pore stage. We here report that a homologous disulfide mutant derived from the homologous toxin pyolysin fails to oligomerize. The mutant also interferes with the activity of wild type PLO in a
Materials and Methods

Construction, Expression and Purification of PLO Mutants. The mutants created for this
investigation were based on on the plasmid pJGS59 (9) encoding the PLO wild type gene, fused to an N-terminal hexa-histidine purification tag. Site directed mutagenesis was performed according to (10) . Introduction of mutations, and absence of any unintended second site mutations was confirmed by DNA sequencing (McMaster University, ON). For expression, the mutant plasmids were transformed into E. coli BL21 and cultured in 2xYT broth supplemented with 0.5mM IPTG (BioShop, Burlington ON) for protein expression. After harvesting, cells were lysed using a Emulsiflex C5 Emulsifier (Avestin, Ottawa ON) and the protein was purified using a BioRad Biologic LP liquid chromatography system (Mississauga ON) with a nickel agarose column (Qiagen, Mississauga ON). Spectra were subtracted with erythrocyte ghost suspension as a blank.
Chemical Modification of Cysteine
Time-resolved fluorescence was measured using an FT-100 compact fluorescence lifetime spectrometer (PicoQuant, Berlin, Germany) using an LDH-P-C-470 LED laser light source.
Fluorescein emission was isolated using a 520±5nm bandpass filter (Andover, Salem, NH).
Decays were fitted using FluoFit software (PicoQuant) fitting to three lifetime components from which the average lifetime <τ> was calculated, using the formula Microplate Spectrophotometer.
Transmission Electron Microscopy.
Wild type PLO and of PLO-DS, alone or in mixtures as indicated in the Results section, were incubated at a total protein concentration of 0.125 mg/ml with cholesterol crystals (0.5 mg/ml, prepared according to (11) ) for 30 minutes at room temperature. The samples were subjected to negative staining with 2% uranyl acetate according to (12) . TEM study of the negatively stained specimens was performed in a Phillips CM 100 transmission electron microscope at 100 kV. Digital images were recorded using an Optronics 
Results
Hemolytic Activity of the disulfide-tethered mutant. The hemolytic activity of the disulfide mutant R219C/G85C, or PLO-DS for short. The PLO-DS is shown in Figure 2 . Wild type PLO (PLO-WT) exhibits 50% hemolysis at approximately 400 ng/ml. In contrast, PLO-DS shows no hemolytic activity up to a concentration of 30 μg/ml. However, when PLO-DS is reduced with DTT, the hemolytic activity was restored to a level similar to that of wild type pyolysin. This
indicates that the functional impairment is due to the disulfide bond and not to the substitutions of residues R219C or G85C individually. These findings are entirely analogous to those reported previously for the homologous mutant of perfringolysin O (8).
PLO-DS does not form oligomers.
The disulfide mutant of perfringolysin O was reported to form pre-pores on membranes, with the same circular shape and diameter that also characterizes the final, membrane-inserted perfringolysin pores. In contrast to these prior findings, PLO-DS did not form any distinct, regular ring-shaped oligomers on PC/cholesterol liposome membranes (not shown) or cholesterol crystals ( Figure 3A) .
Similarly, on cholesterol microcrystals, which provide a minimal but viable model substrate for 50 Å (14) , which is well above the distance of two adjacent subunits in CDC oligomers (2; 15).
Accordingly, when mixtures of fluorescein-and rhodamine-labeled N90C are incubated with membranes, the formation of hybrid oligomers results in a strong reduction of the fluorescein emission ( Figure 4A ). In contrast, no such reduction is apparent with the triple mutant, indicating absence of oligomerization ( Figure 4B ).
Effect of PLO-DS on the Oligomerization of Wild Type PLO.
When PLO-DS was added to wild type PLO at equal amounts or in slight excess, oligomers were observed, but these were mostly incomplete and arc-shaped, indicating that oligomerization was partially inhibited by the mutant ( Figure 3C ). With PLO-DS present in tenfold excess, oligomerization was virtually completely inhibited ( Figure 3D ). and inactive ( Figure 4B ) mutants alone, indicating that the two proteins become incorporated into hybrid oligomers, although the formation of these hybrids appears to be less efficient than the oligomerization of active toxin alone. When wild type PLO or the unlabeled disulfide mutant is added to a mixture of N90C-fluorescein and N90C-rhodamine, they reduce FRET between the two labeled species, indicating the intercalation of unlabeled molecules between the labeled ones in hybrid oligomers ( Figure 4D ). This effect is greater with wild type toxin than with PLO-DS. upon transition from an aqueous to a non-polar environment (7). The insertion of hybrids was studied using the NBD-labeled mutants K231C and A329C, whose cysteine residues are located the first and second hairpin, respectively. When either NBD-labeled mutant was mixed with a twofold excess of the unlabeled PLO-DS, the NBD fluorescence emission was reduced significantly compared to samples that were prepared in the same manner but with unlabeled PLO-WT instead of PLO-DS ( Figure 6 ). However, in both cases, the NBD fluorescence was still well above of that observed with the equivalent amount of toxin not incubated with membranes.
The steady-state spectra are in line with time-resolved fluorescence measurements. For mutant K231C, the average excited state lifetime of NBD was was 4.0 ns when mixed with wild type toxin, 3.2 ns when mixed with disulfide mutant, and 1.7 ns in the absence of membranes. For A329C, the lifetimes were 6.2 ns, 2.9 ns, and 2.1 ns, respectively. These findings indicate that
Reduction of average pore size by PLO-DS. When PLO-DS is combined with active PLO, it is
likely that only a small fraction of all resulting oligomers will not contain any PLO-DS at all.
This suggests that the remaining extent of membrane insertion and pore formation observed with such mixtures is at least in part associated with hybrid oligomers. Since these hybrid oligomers are reduced in size, the pores associated with them should be smaller than those formed by fullsize, ring-shaped oligomers formed by wild type PLO alone.
Differences in functional pore size can be studied in hemolytic assays using osmotic protection.
In this method, the extracellular medium is supplemented with inert macromolecular solutes such as dextran that counteract the osmotic activity of the intracellular hemoglobin. When pore formation occurs, hemolysis will result only if the pores are large enough to permit equilibration of the macromolecular solutes across the membrane, so that they no longer maintain the balance with hemoglobin. On the other hand, if the effective diameter of the protecting solutes exceeds that of the pores, the solutes will remain excluded from the cell and continue to protect it from osmotic lysis. Differential protection by macromolecular solutes varying in size can be used to characterize the pore size.
In the experiment shown in Figure 8A , wild type PLO was incubated with red cells without dextran 6 and dextran 40, respectively. The dextrans cause only a very slight delay in the time course of hemolysis. This is consistent with the fact that the hydrodynamic diameters of dextran 6 (M r 6000) and dextran 40 (M r 6000), at approximately 3 and 10 nm, respectively (16) , are smaller than the diameter of ring-shaped PLO oligomers (1) and therefore do not afford osmotic protection against the latter.
The picture changes, however, when the wild type PLO is supplemented with one ( Figure 8B 
Discussion
The results of this study show a remarkable and surprising difference between the disulfidetethered PLO mutant and the homologous mutant previously described for perfringolysin O (8).
Whereas the latter mutant retains the ability to assemble into complete, ring-shaped pre-pores on membranes, PLO-DS does no longer oligomerize on its own. This discrepancy may be related to a subtle yet long-ranging conformational change that is triggered by membrane binding and whose interception by mutagenesis interferes with proper oligomerization (18; 19) . It seems possible that the presence of the disulfide bond may interfere with this conformational shift to different extents in PLO and perfringolysin, preventing oligomerization in one case but not the other.
The notion that the difference in the functional defect between the two disulfide mutants is quantitative rather than qualitative is supported by the finding that PLO-DS retains the ability to form hybrid oligomers with wild type PLO. A possible explanation of this observation would be a 'hemiplegic' inactivation of the mutant, such that it can attach to a growing oligomer of wild type molecules using its remaining active oligomerization surface, which would then leave the inactive one exposed and so terminate the further growth of the oligomer. In this case, however, PLO-DS should be confined to one end of a hybrid oligomer and be able to intercalate between active subunits. This is not in line with the observation that unlabeled PLO-DS can significantly reduce FRET between labeled, hemolytically active mutants within hybrid oligomers.
Another possible explanation for the incorporation of PLO-DS into hybrid but not homogeneous oligomers may be related to the existence of different kinetic stages of oligomerization (20) . In the rate-limiting initiation reaction, two or more monomers react with one another, and the kinetic handicaps of multiple mutant molecules would likely act additively at this stage. In contrast, in the subsequent extension stage, growing oligomers reacts with further monomers one at a time. In this reaction, kinetic obstruction would only apply to one of the partners and therefore more readily overcome. Nevertheless, even in this situation, oligomerization of PLO-DS is inhibited, resulting in the formation of incomplete, arc-shaped oligomers. Thus, wild type toxin promotes the oligomerization of the disulfide mutant, yet the latter inhibits oligomerization of the former; neither is entirely dominant.
Another interesting finding of this study is the pattern of hemolytic activity and of membrane insertion observed with hybrid oligomers. Mixing wild type PLO and PLO-DS likely produces a distribution of oligomers that differ not only in size but also in composition, with some oligomers containing a higher proportion of the disulfide mutant than others. Some oligomers containing no PLO-DS at all should also form; however, at a twofold excess of PLO-DS over wild type PLO, their number should be small. At this same ratio, approximately 50% of both membrane insertion and hemolytic activity is still preserved. Some of this remaining activity must therefore be associated with hybrid oligomers. This conclusion is supported by the fact that pores formed under these conditions are smaller on average than those formed by wild type toxin only. In contrast, at fourfold or greater excess of PLO-DS, electron microscopy still shows appreciable formation of arc-shaped oligomers, but hemolysis is sharply reduced; most oligomers therefore seem to be arrested at the pre-pore stage.
These results signify that, with respect to membrane insertion as with oligomerization, neither the wild type toxin nor PLO-DS is clearly dominant over the other. Insertion of hybrids formed at moderate proportions of PLO-DS indicates that not all subunits of an oligomer need to participate in its membrane insertion. On the other hand, its suppression by PLO-DS in greater proportion indicates that membrane insertion requires a certain critical proportion of active subunits. Overall, these findings suggest that membrane insertion requires the cooperation of a number of adjacent subunits within the oligomer.
In conclusion, our study provides additional insights into the mechanism of oligomerization and pore formation by CDCs. The initial conformational change that is associated with membrane binding and which sets the stage for oligomerization (ref) involves conformational flexibility between domains 2 and 3. The complementation of PLO-DS oligomerization by wild type PLO supports a two-step model of oligomerization that so far had been based on kinetic modeling only (20) . The fact that membrane insertion and pore formation can occur in oligomers that contain some insertion-deficient subunits indicates that the process of insertion is only partially cooperative. 
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